Balyasny Asset Management
CANO

Balyasny Asset Management’s Cano Health, Inc. CANO Stock Holding History

Balyasny Asset Management’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,157
Closed -$1.67M – 3313
2022
Q4 		$1.67M Buy
12,157
+3,926
+48% +$1.33M ﹤0.01% 1485
2022
Q3 		$7.14M Buy
8,231
+1,232
+18% +$772K 0.02% 837
2022
Q2 		$3.07M Sell
6,999
-2,557
-27% -$1.33M 0.01% 1168
2022
Q1 		$6.07M Sell
9,556
-12,861
-57% -$8.11M 0.02% 877
2021
Q4 		$20M Buy
22,417
+4,734
+27% +$4.97M 0.07% 411
2021
Q3 		$22.4M Buy
17,683
+2,270
+15% +$2.75M 0.09% 306
2021
Q2 		$18.6M Buy
15,413
+2,879
+23% +$3.88M 0.09% 310
2021
Q1 		$16.6M Buy
12,534
+9,176
+273% +$13M 0.08% 324
2020
Q4 		$4.5M Buy
+3,358
New +$3.84M 0.03% 680

Other funds holding CANO

DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Balyasny Asset Management's CANO Position: Q1 2023 in Review

Balyasny Asset Management sold out of Cano Health, Inc. (CANO) in Q1 2023, closing a stake of 12,157 shares — an estimated $1.67M sold.

Balyasny Asset Management first reported a position in CANO in Q4 2020 and held it in 9 quarters. The position peaked at $22.4M in Q3 2021. 163 funds tracked by Wall St. Rank hold CANO as of Q1 2023.

  • Balyasny Asset Management reported no remaining Cano Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 12,157 Cano Health, Inc. shares in Q1 2023, an estimated $1.67M.
  • Balyasny Asset Management first reported a position in Cano Health, Inc. in Q4 2020 and held it in 9 quarters.
  • Balyasny Asset Management's Cano Health, Inc. position peaked at $22.4M in Q3 2021.
  • 163 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.